Syndrome d’hypersensibilité médicamenteuse ou DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms)

Coope, 1940, Treatment of epilepsy with sodium diphenyl hydantoine, Lancet, i, 490, 10.1016/S0140-6736(00)61376-4

Saltztein, 1959, Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically and pathologically malignant lymphomas, Cancer, 12, 164, 10.1002/1097-0142(195901/02)12:1<164::AID-CNCR2820120122>3.0.CO;2-Y

Callot, 1996, Drug induced pseudolymphoma and hypersensitivity syndrome : two different clinical entities, Arch Dermatol, 132, 1315, 10.1001/archderm.1996.03890350057010

Bocquet, 1996, Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS), Semin Cutan Med Surg, 15, 250, 10.1016/S1085-5629(96)80038-1

Singer, 1986, The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality, Arthritis Rheum, 29, 82, 10.1002/art.1780290111

Kaur, 2002, Anticonvulsant hypersensitivity syndrome, Pediatr Dermatol, 19, 142, 10.1046/j.1525-1470.2002.00045.x

Tomecki, 1981, Dapsone hypersensitivity. The sulfone syndrome revisited, Arch Dermatol, 117, 38, 10.1001/archderm.1981.01650010044023

Antunes, 1999, Syndrome d’hypersensibilité à la minocycline, Ann Dermatol Venereol, 126, 518

Bonnetblanc, 1998, Le syndrome d’hypersensibilité médicamenteuse : à la recherche de son identité, Ann Dermatol Venereol, 125, 309

Tennis, 1997, Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate : a record linkage study, Neurology, 49, 542, 10.1212/WNL.49.2.542

Gennis, 1991, Familial occurrence of hypersensitivity to phenytoin, Am J Med, 91, 631, 10.1016/0002-9343(91)90216-K

Warmock, 2002, Adverse cutaneous reactions to antidepressants, Am J Clin Dermatol, 3, 329, 10.2165/00128071-200203050-00005

Mallal, 2002, Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir, Lancet, 359, 727, 10.1016/S0140-6736(02)07873-X

Kleier, 1991, Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome, Arch Dermatol, 127, 1361, 10.1001/archderm.1991.01680080097009

Parneix Spake, 1995, Minocycline as a possible cause of severe and protracted hypersensitivity drug reaction, Arch Dermatol, 131, 490, 10.1001/archderm.131.4.490

Pohle, 2000, Minocycline and fulminant hepatic failure necessitating liver transplantation, Am J Gastroenterol, 95, 560, 10.1111/j.1572-0241.2000.t01-1-01809.x

Mitchell, 1981, Granulomatous hepatitis associated with carbamazepine therapy, Am J Med, 71, 733, 10.1016/0002-9343(81)90244-8

Hogg, 1981, Carbamazepine-induced acute tubulointerstitial nephritis, J Pediatr, 98, 830, 10.1016/S0022-3476(81)80861-X

Guillon, 1992, Minocycline-induced cell-mediated hypersensitivity pneumonitis, Ann Intern Med, 117, 476, 10.7326/0003-4819-117-6-476

Engel, 1986, Phenytoin hypersensitivity: a case of severe acute rhabdomyolysis, Am J Med, 81, 928, 10.1016/0002-9343(86)90371-2

Gupta, 1992, Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides, Clin Pharmacol Ther, 5, 56, 10.1038/clpt.1992.8

Chattergoon, 1997, Multiorgan dysfunction and disseminated intravascular coagulation in children receiving lamotrigine and valproic acid, Neurology, 49, 1442, 10.1212/WNL.49.5.1442

Sekine, 2001, Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome, JAMA, 285, 1153, 10.1001/jama.285.9.1153

Colvin, 2001, Minocycline hypersensitivity syndrome with hypotension mimicking septic shock, Pediatr Dermatol, 18, 295, 10.1046/j.1525-1470.2001.01931.x

Fujino, 2002, Human herpes virus 6 encephalitis associated with hypersensitivity syndrome, Ann Neurol, 51, 771, 10.1002/ana.10194

Tohyama, 1998, Severe hypersensitivity syndrome due to sulfalasazine associated with reactivation of human herpes virus 6, Arch Dermatol, 134, 1113, 10.1001/archderm.134.9.1113

Dijen, 1999, Sémiologie et marqueurs de sévèrité des toxidermies érythémateuses, Ann Dermatol Venereol, 126, 247

Clay, 2002, The abacavir hypersensitivity reaction : a review, Clin Ther, 24, 1502, 10.1016/S0149-2918(02)80057-1

Descamps, 2001, Association of human herpes virus 6 infection with drug reaction with eosinophilia and systemic symptoms, Arch Dermatol, 137, 301

Suzuki, 2000, Human herpes virus 6 infection as a risk factor for the developpment of severe drug-induced hypersensitivity syndrome, Arch Dermatol, 136, 1108

Tohyama, 2002, Drug hypersensitivity syndrome and human herpesvirus 6 reactivation, Arch Dermatol, 138, 268, 10.1001/archderm.138.2.268

Aihara, 2001, Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus, Br J Dermatol, 144, 1231, 10.1046/j.1365-2133.2001.04239.x

Descamps, 2003, Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection, Br J Dermatol, 148, 1032, 10.1046/j.1365-2133.2003.05330.x

Regnier, 2000, Primo-infection à Parvovirus B19 mimant un syndrome d’hypersensibilité médicamenteuse, Ann Dermatol Venereol, 127, 505

Kosseian-Bal, 1998, Syndrome d’hypersensibilité durant une infection à Mycoplasma pneumoniae, Ann Dermatol Venereol, 125, 328

Knowles, 2000, Idiosyncratic drug reactions : the reactive metabolite syndromes, Lancet, 356, 1587, 10.1016/S0140-6736(00)03137-8

Eliaszewicz, 2002, Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS, J Am Acad Dermatol, 47, 40, 10.1067/mjd.2002.120468

Hashizume, 2002, Characterization of drug-specific T cells in phenobarbital-induced eruption, J Immunol, 168, 5359, 10.4049/jimmunol.168.10.5359

Choquet-Kastylevsky, 1998, Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome, Br J Dermatol, 139, 1026, 10.1046/j.1365-2133.1998.02559.x

Tas, 2003, Management of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS Syndrome) : An Update, Dermatology, 206, 353, 10.1159/000069956

Morand, 2001, Syndrome d’hypersensibilité médicamenteuse rapidement résolutif après perfusion d’immunoglobulines humaines, Ann Dermatol Venereol, 128, 1351

Beneton, 1997, Benefit-risk assessment of acne therapies, Lancet, 349, 1252, 10.1016/S0140-6736(05)62446-4